These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8444595)

  • 1. Prevalence of hepatitis C antibodies in patients with liver disorders in the west of Ireland.
    Gokulan C; O'Gorman T; Corbett-Feeney G; McCarthy CF
    Ir Med J; 1993 Jan; 86(1):32-3. PubMed ID: 8444595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis C in patients with sickle cell disease.
    Hasan MF; Marsh F; Posner G; Bellevue R; Dosik H; Suatengco R; Ramani N
    Am J Gastroenterol; 1996 Jun; 91(6):1204-6. PubMed ID: 8651171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
    Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
    Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
    Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
    J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa.
    Jeannel D; Fretz C; Traore Y; Kohdjo N; Bigot A; Pê Gamy E; Jourdan G; Kourouma K; Maertens G; Fumoux F; Fournel JJ; Stuyver L
    J Med Virol; 1998 Jun; 55(2):92-7. PubMed ID: 9598927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
    Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
    Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
    Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
    Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late liver-related mortality from complications of transfusion-acquired hepatitis C.
    Kamitsukasa H; Harada H; Tanaka H; Yagura M; Tokita H; Ohbayashi A
    Hepatology; 2005 Apr; 41(4):819-25. PubMed ID: 15793849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
    Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
    Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated risk of transmission of hepatitis C virus by blood transfusion.
    Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
    Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of anti-HCV antibodies in patients with lichen planus.
    Mahboob A; Haroon TS; Iqbal Z; Iqbal F; Butt AK
    J Coll Physicians Surg Pak; 2003 May; 13(5):248-51. PubMed ID: 12757670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis C virus infection in children admitted to an urban hospital.
    Gerner P; Wirth S; Wintermeyer P; Walz A; Jenke A
    J Infect; 2006 Apr; 52(4):305-8. PubMed ID: 16473408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between chronic liver diseases and hepatitis C in Burundi adults].
    Aubry P; Larouze B; Muhirwa G; Henzel D; Ndabaneze E; Nsabimana JM
    Med Trop (Mars); 1995; 55(3):235-7. PubMed ID: 8559018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
    Williams JL; Cagle HH; Christensen CJ; Fox-Leyva LK; McMahon BJ
    Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of hepatitis C virus infection in the largest province of Pakistan.
    Idrees M; Lal A; Naseem M; Khalid M
    J Dig Dis; 2008 May; 9(2):95-103. PubMed ID: 18419643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
    Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.